Professor Jon Emery MA, MBBCh, FRACGP, MRCGP, DPhil

Affiliation

University of Melbourne

Role

Professor of Primary Care Cancer Research

Competing interest

This person has declared the following competing interest:
Chief investigator on a research project investigating a non-endoscopic approach to screening for Barrett’s oesophagus in primary care. No pecuniary interest in the associated cytosponge screening test.

My pages

• Clinical question:Aspirin for prevention of colorectal cancer (body of evidence· view literature search summary)— Co-author

• Clinical question:Colorectal cancer screening test accuracy (body of evidence· view literature search summary)— Co-author

• Clinical question:Diagnosis interval in colorectal cancer (body of evidence· view literature search summary)— Author

• Clinical question:Family history and CRC risk (body of evidence· view literature search summary)— Co-author

• Clinical question:For which populations is screening for BO cost-effective? (body of evidence· view literature search summary)— Author

• Clinical question:Population screening in colorectal cancer (body of evidence· view literature search summary)— Co-author

• Clinical question:Symptoms predictive of colorectal cancer (body of evidence· view literature search summary)— Author

• Guidelines:Colorectal cancer/Population screening age evidence — Co-author

• Guidelines:Colorectal cancer/Population screening cost effectiveness evidence — Co-author

• Guidelines:Colorectal cancer/Population screening discussion — Co-author

• Guidelines:Colorectal cancer/Population screening for colorectal cancer — Co-author

• Guidelines:Colorectal cancer/Population screening recommendations — Co-author

• Guidelines:Colorectal cancer/Primary prevention — Co-author

• Guidelines:Colorectal cancer/Primary prevention dietary and lifestyle — Co-author

• Guidelines:Colorectal cancer/Risk and screening based on family history — Co-author

• Guidelines:Colorectal cancer/Screening based on family history — Co-author

• Guidelines:Colorectal cancer/The symptomatic patient — Author

• Guidelines:The symptomatic patient — Co-author

Pending critical appraisals

Clinical question	Citation
Are there any treatments that prevent progression of BO to cancer?	Hur C, Nishioka NS, Gazelle GS 2004	Complete this critical appraisal

Completed critical appraisals

• Barbiere JM, Lyratzopoulos G 2009"

• Benaglia T, Sharples LD, Fitzgerald RC, Lyratzopoulos G 2012"

• Gerson L, Lin OS 2007"

• Gerson LB, Groeneveld PW, Triadafilopoulos G 2004"

• Gupta N, Bansal A, Wani SB, Gaddam S, Rastogi A, Sharma P 2011"

• Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N 2003"

• Nietert PJ, Silverstein MD, Mokhashi MS, Kim CY, Glenn TF, Marsi VA, et al 2003"

• Rubenstein JH, Inadomi JM 2006"

• Rubenstein JH, Inadomi JM, Brill JV, Eisen GM 2007"

• Soni A, Sampliner RE, Sonnenberg A 2000"